CSF1 and cancer: Our findings suggest that CSF1, which has been a target of interest for cancers, Alzheimer’s disease, and other disorders [78, 79], may be a novel target to alleviate negative affect during withdrawal from chronic alcohol exposure contributing to relapse-like behavior.